Randa Latif

Dr. Randa Latif


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2011 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
CRChristianne Mounir Zaki Rizkalla
Christianne Mounir Zaki Rizkalla
RLRanda Latif
Randa Latif
ISIman Ibrahim Soliman
Iman Ibrahim Soliman

21 October 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Mai Mohamed ElhalawanyMai Mohamed Elhalawany
Mai Mohamed Elhalawany
RLRanda Latif
Randa Latif
MAMohamed H.H. AbouGhaly
Mohamed H.H. AbouGhaly
Wound control in patients on anticoagulants is challenging and often leads to poor hemostasis. They have a higher tendency to develop alveolar osteitis after tooth extraction. The application of a hemostatic dressing that has a high absorbing capacity and is loaded with an antifibrinolytic drug could help in controlling the bleeding. Alginate/nano-hydroxyapatite (SA/Nano-HA) composite aerogels loaded with tranexamic acid (TXA) were prepared. Nano-HA served as a reinforcing material for the alginate matrix and a source of calcium ions that helps in blood clotting. It influenced the porosity and the water uptake capacity. TXA release from SA/Nano-HA aerogels showed a biphasic profile for up to 4 h. Blood coagulation studies were performed on human whole blood. The TXA-loaded aerogel significantly reduced the clotting time by 69% compared to the control (p < 0.0001). Recalcification time was significantly reduced by 80% (p < 0.0001). Scanning electron microscopy analysis revealed the porous nature of the aerogels and the ability of the optimum aerogel to activate and adhere platelets to its porous surface. The cell migration assay showed that there was a delay in wound healing caused by the TXA aerogel compared to the control sample after treating human fibroblasts. Results suggest that the developed aerogel is a promising dressing that will help in hemostasis after tooth extraction.

8 October 2023 in Drug Delivery and Translational Research
Verified
Journal Article
Open access
PDF file
RHReham Waheed Hammad
Reham Waheed Hammad
RSRania Abdel-Basset Sanad
Rania Abdel-Basset Sanad
NANevine Shawky Abdelmalak
Nevine Shawky Abdelmalak
RLRanda Latif
Randa Latif
A well-made chitosan-PVP block copolymer platform was equipped with highly ordered and uniform nano-channels. This highly adhesive block copolymer platform was designed to ensure the efficient co-delivery of two synergistic-acting hypoglycemic drugs. Linagliptin oral bioavailability is 30% due to poor permeability and intestinal degradation. Its pharmacokinetics shows a non-linear profile. Empagliflozin exhibited decreased permeability and decreased solubility in aqueous media between pH 1 and 7.5. Cubosomes were functionalized as a good microdomain to guest and improve the physicochemical characteristics of drug molecules with decreased permeability and solubility. Cubosomes loaded with linagliptin (linagliptin cubosomes (LCs)) and empagliflozin (empagliflozin cubosomes ECs) were separately prepared using the top-down method and optimized by applying 23 factorial design. Optimized cubosomal systems LCs (F3) and ECs (F4) were incorporated into a chitosan-PVP gel to obtain dual cubosome-loaded platforms (LECF) optimized through 22 factorial design. The permeation study from the optimized LECF (C1) ensured enhanced empagliflozin permeation alongside continued efflux for linagliptin, resolving potential risks due to its non-linear plasma profile. The in-vivo study revealed that AUC(0–∞) of linagliptin and empagliflozin was enhanced by 2- and threefold, respectively. Therefore, the chitosan-PVP block copolymer platform buccal application for the co-delivery of linagliptin and empagliflozin could contribute to enhanced clinical effectiveness in treating diabetes. Graphical Abstract Graphical abstract showing dual cubosome-loaded platform tested in-vivo using a rabbit model

14 September 2022 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
RHReham Waheed Hammad
Reham Waheed Hammad
RSRania Abdel-Basset Sanad
Rania Abdel-Basset Sanad
NANevine Shawky Abdelmalak
Nevine Shawky Abdelmalak
RLRanda Latif
Randa Latif

2 October 2018 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
RHReham Waheed Hammad
Reham Waheed Hammad
RSRania Abdel Baset Sanad
Rania Abdel Baset Sanad
NANevine Shawky Abdelmalk
Nevine Shawky Abdelmalk
RLRanda Latif
Randa Latif
FTFaisal A. Torad
Faisal A. Torad

1 February 2021 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
RLRanda Latif
Randa Latif
RMRana R. Makar
Rana R. Makar
EHEhab A. Hosni
Ehab A. Hosni
OGOmaima N. El Gazayerly
Omaima N. El Gazayerly
The present work focuses on improving zaleplon (ZAP) performance through nanosizing its insoluble particles which were then delivered intranasally in powder form. Since nanopowders have an exceptio...